IMIC(SZ:000516) Xin Lang Cai Jing·2025-08-27 14:18Core Viewpoint - Xi'an International Medical Investment Co., Ltd. has made significant progress in its operational development in the first half of 2025, focusing on enhancing service quality, optimizing operational efficiency, and expanding its business layout [2][3]. Group 1: Operational Achievements - In the first half of 2025, the company achieved a total outpatient and emergency service volume of 1.3191 million visits, a year-on-year increase of 5.42%, while inpatient service volume decreased by 4.01% to 96,300 visits [3]. - The company reported a revenue of 2,034.31 million yuan, a year-on-year decrease of 15.95%, and a net profit attributable to shareholders of -164.96 million yuan, a reduction in losses by 4.98% [3]. - The net operating cash flow was 592.54 million yuan, reflecting a year-on-year increase of 12.75%, indicating stable medical business collections and good capital turnover [3]. Group 2: Business Development and Innovations - The company established new specialized clinical departments and completed 636 clinical application filings for restricted technologies, along with obtaining 24 national authorized patents [2]. - The company has expanded its service offerings by establishing specialized treatment services such as geriatrics and proton therapy to meet market demand [2]. - The integration of artificial intelligence and the expansion of internet hospital services have improved patient service processes and enhanced operational efficiency [2]. Group 3: Financial Performance of Subsidiaries - Xi'an High-tech Hospital reported an outpatient service volume of 578,700 visits, a year-on-year increase of 3.04%, while inpatient service volume decreased by 6.48% [4]. - Xi'an International Medical Center Hospital had an outpatient service volume of 740,400 visits, a year-on-year increase of 7.37%, but a net profit of -113.21 million yuan, a decrease of 44.63% [4]. Group 4: Future Strategies - The company plans to enhance cost control through bed integration and departmental optimization, as well as increase the use of drugs that meet DRG payment standards [5]. - The focus will be on health management, aesthetic medicine, physical examinations, elderly care, and international cooperation to implement differentiated business strategies [5]. - The company aims to strengthen cost control and efficiency while enhancing medical quality and service experience to build competitive advantages and achieve steady growth [6].